Skip to main content
Beat Cancer EU Website Logo
IGHG Male Gonadotoxicity Surveillance Recommendations
Quality of LifeAllGuidelines

IGHG Male Gonadotoxicity Surveillance Recommendations

Recommendations for surveillance in male survivors who are at risk of impaired spermatogenesis, testosterone deficiency or physical sexual dysfunction

Year:2017

Male childhood, adolescent and young adult cancer survivors treated with chemotherapy, or radiotherapy, or surgery involving reproductive organs have an increased risk of impaired spermatogenesis, testosterone deficiency and/or physical sexual dysfunction.

Because of this high risk survivors may benefit from surveillance.

Discussion & Questions

Note: Comments are for discussion and clarification only. For medical advice, please consult with a healthcare professional.

Leave a Comment

Minimum 10 characters, maximum 2000 characters

No comments yet

Be the first to share your thoughts!